Symbol
KTTA on Nasdaq
Investment type
Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Ownership
318K shares
Security Ownership
4.99%

Mitchell P. Kopin ownership in Pasithea Therapeutics Corp. Common Stock, $0.0001 par value per share (KTTA)

2025-05-12 - Mitchell P. Kopin has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 318K shares of Pasithea Therapeutics Corp. Common Stock, $0.0001 par value per share (KTTA). This represents 4.99% percent ownership of the company.